302 related articles for article (PubMed ID: 20393380)
1. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.
Marra CM; Tantalo LC; Sahi SK; Maxwell CL; Lukehart SA
Sex Transm Dis; 2010 May; 37(5):283-7. PubMed ID: 20393380
[TBL] [Abstract][Full Text] [Related]
2. Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients.
Hu R; Lu C; Lu S; Hu Y; Ma H; Lai W; Zhu G; Feng P; Lu R; Li Y
Int J STD AIDS; 2016 Feb; 27(2):141-6. PubMed ID: 25769888
[TBL] [Abstract][Full Text] [Related]
3. Has CXCL13 an added value in diagnosis of neurosyphilis?
Mothapo KM; Verbeek MM; van der Velden LB; Ang CW; Koopmans PP; van der Ven A; Stelma F
J Clin Microbiol; 2015 May; 53(5):1693-6. PubMed ID: 25788544
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid CXCL13 concentration for diagnosis and monitoring of neurosyphilis in people with HIV.
Carvalho RS; Rangel IC; Soane MM; Bacarov NBS; Herbst V; Ferry FRA
AIDS; 2024 Apr; 38(5):657-668. PubMed ID: 38079581
[TBL] [Abstract][Full Text] [Related]
5. Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals.
Marra CM; Tantalo LC; Maxwell CL; Dougherty K; Wood B
Neurology; 2004 Jul; 63(1):85-8. PubMed ID: 15249615
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic role of CXCL13 and CSF serology in patients with neurosyphilis.
Li D; Huang X; Shi M; Luo L; Tao C
Sex Transm Infect; 2021 Nov; 97(7):485-489. PubMed ID: 33436504
[TBL] [Abstract][Full Text] [Related]
7. Serum TRSUT Titer ≥1: 16 Is a Predictor for Neurosyphilis Among HIV-Infected Patients With Concurrent Syphilis and No Neurological Symptoms.
Sun JJ; Wang ZY; Shen JY; Shen YZ; Liu L; Wang JR; Zhang RF; Lu HZ
Medicine (Baltimore); 2015 Nov; 94(45):e2023. PubMed ID: 26559304
[TBL] [Abstract][Full Text] [Related]
8. CXCL13 and TH1/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients.
Yan Y; Wang J; Qu B; Zhang Y; Wei Y; Liu H; Wu C
Medicine (Baltimore); 2017 Nov; 96(47):e8850. PubMed ID: 29381995
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid human immunodeficiency virus viral load in patients with neurosyphilis.
de Almeida SM; Bhatt A; Riggs PK; Durelle J; Lazzaretto D; Marquie-Beck J; McCutchan A; Letendre S; Ellis R
J Neurovirol; 2010 Feb; 16(1):6-12. PubMed ID: 20132081
[TBL] [Abstract][Full Text] [Related]
10. CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients.
Wang C; Wu K; Yu Q; Zhang S; Gao Z; Liu Y; Ni L; Cheng Y; Guan Z; Shi M; Lu H; Lou Y; Zhou P
Sci Rep; 2016 Sep; 6():33569. PubMed ID: 27650493
[TBL] [Abstract][Full Text] [Related]
11. Neurosyphilis Increases Human Immunodeficiency Virus (HIV)-associated Central Nervous System Inflammation but Does Not Explain Cognitive Impairment in HIV-infected Individuals With Syphilis.
Ho EL; Maxwell CL; Dunaway SB; Sahi SK; Tantalo LC; Lukehart SA; Marra CM
Clin Infect Dis; 2017 Sep; 65(6):943-948. PubMed ID: 28525592
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Humoral Immune Responses in Neurosyphilis: CXCL13/CXCR5 Play a Pivotal Role for B-Cell Recruitment to the Cerebrospinal Fluid.
Yu Q; Cheng Y; Wang Y; Wang C; Lu H; Guan Z; Huang J; Gong W; Shi M; Ni L; Wu J; Peng R; Zhou P
J Infect Dis; 2017 Sep; 216(5):534-544. PubMed ID: 28931218
[TBL] [Abstract][Full Text] [Related]
13. Expression of CXCL2 in the serum and cerebrospinal fluid of patients with HIV and syphilis or neurosyphilis.
Tsai HC; Ye SY; Lee SS; Wann SR; Chen YS
Inflammation; 2014 Jun; 37(3):950-5. PubMed ID: 24419746
[TBL] [Abstract][Full Text] [Related]
14. HIV and syphilis: when to perform a lumbar puncture.
Libois A; De Wit S; Poll B; Garcia F; Florence E; Del Rio A; Sanchez P; Negredo E; Vandenbruaene M; Gatell JM; Clumeck N
Sex Transm Dis; 2007 Mar; 34(3):141-4. PubMed ID: 16865051
[TBL] [Abstract][Full Text] [Related]
15. Detection of Treponema pallidum by semi-nested PCR in the cerebrospinal fluid of asymptomatic HIV-infected patients with latent syphilis.
Fraga D; Muller AL; Czykiel MS; De Armas Y; Wissmann G; Goldani LZ
Clin Lab; 2014; 60(12):2051-4. PubMed ID: 25651740
[TBL] [Abstract][Full Text] [Related]
16. CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients.
Zeng YL; Lin YQ; Zhang NN; Zou CN; Zhang HL; Peng F; Liu ZJ; Zheng WH; Yan JH; Liu LL
Springerplus; 2016; 5(1):743. PubMed ID: 27376011
[TBL] [Abstract][Full Text] [Related]
17. Screening for asymptomatic neurosyphilis in HIV patients after treatment of early syphilis: an observational study.
Tomkins A; Ahmad S; Cousins DE; Thng CM; Vilar FJ; Higgins SP
Sex Transm Infect; 2018 Aug; 94(5):337-339. PubMed ID: 28196838
[TBL] [Abstract][Full Text] [Related]
18. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.
Gudowska-Sawczuk M; Mroczko B
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331231
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of neurosyphilis in human immunodeficiency virus-infected patients with latent syphilis.
Holtom PD; Larsen RA; Leal ME; Leedom JM
Am J Med; 1992 Jul; 93(1):9-12. PubMed ID: 1626576
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of neurosyphilis in patients infected with human immunodeficiency virus type 1.
Marra CM; Gary DW; Kuypers J; Jacobson MA
J Infect Dis; 1996 Jul; 174(1):219-21. PubMed ID: 8655999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
